EC Number   |
Inhibitors |
Structure |
|---|
   2.3.1.20 | (1R,2R)-2-[4'-[(phenylcarbamoyl)amino][1,1'-biphenyl]-4-carbonyl]cyclopentane-1-carboxylic acid |
- |
   |
| 2.3.1.20 | (2alpha,3beta)-2,3-dihydroxyurs-12-en-28-oic acid |
IC50: 0.0443 mM |
|
| 2.3.1.20 | (2E)-1-[2,4-dihydroxy-6-methoxy-3-[(2R)-5-methyl-2-(1-methylethenyl)hex-4-en-1-yl]phenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one |
IC50: 0.0098 mM |
|
| 2.3.1.20 | (2E,4Z,8E)-N-[9-(3,4-methylenedioxyphenyl)-2,4,8-nonatrienoyl]piperidine |
IC50: 0.0298 mM, isolated from the extracts of fruits of Piper longum and Piper nigrum |
|
| 2.3.1.20 | (2R,3R)-2-(2,4-Dihydroxy-phenyl)-3,7-dihydroxy-8-((R)-5-hydroxy-2-isopropenyl-5-methyl-hexyl)-5-methoxy-chroman-4-one |
i.e. kushenol H, prenylflavonoid from Sophora flavescens, 50% inhibition at 0.142 mM |
|
| 2.3.1.20 | (2R,3S)-2-(2,4-Dihydroxy-phenyl)-3,7-dihydroxy-8-((R)-5-hydroxy-2-isopropenyl-5-methyl-hexyl)-5-methoxy-chroman-4-one |
i.e. kushenol K, prenylflavonoid from Sophora flavescens, 50% inhibition at 0.250 mM |
|
| 2.3.1.20 | (2S)-1-(3-[[(2S)-1-ethoxy-4-phenylbutan-2-yl]sulfamoyl]anilino)-4-methyl-1-oxopentan-2-yl 2,2-dimethylpropanoate |
- |
|
| 2.3.1.20 | (2S)-1-[(1-[[(1S)-1-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-3-phenylpropyl]carbamoyl]cyclopentyl)amino]-4-methyl-1-oxopentan-2-yl 2,2-dimethylpropanoate |
- |
|
| 2.3.1.20 | (4-[4-[4-(2-amino-5-chlorobenzamido)phenyl]thieno[3,2-d]pyrimidin-7-yl]cyclohexyl)acetic acid |
- |
|
| 2.3.1.20 | (4-[4-[4-(3-chlorobenzamido)phenyl]thieno[3,2-d]pyrimidin-7-yl]cyclohexyl)acetic acid |
- |
|
